₹521.6▲0.31%
Day's Volatility:
38.46%
Low
52 Weeks Volatility:52.51%
High
14.05%
Returns % | |
1 Month Return | 16.76 % |
3 Month Return | -3.32 % |
1 Year Return | 46.83 % |
Market Stats | |
Previous Close | ₹520.00 |
Open | ₹521.60 |
Volume | 2.00L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,709.83Cr |
Organisation | Aarti Pharmalabs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarti Pharmalabs Ltd
According to a 2 Stage Free Cash Flow to Equity analysis, Aarti Pharmalabs appears to be trading close to its estimated fair value. While earnings declined over the past year and dividends are low compared to top payers in the Pharmaceuticals market, debt is not viewed as a risk and the current share price is below the estimate of fair value.
Aarti Pharmalabs' Net Debt Decreases to INR 1.47B - 21 Mar, 2024
Aarti Pharmalabs had a net debt of INR 1.47B as of September 2023, with a low net debt to EBITDA ratio of only 0.43 and an EBIT that covers its interest expense 18.7 times over. However, the company recorded negative free cash flow in the last three years, making investors cautious about its debt levels.
Fundamentals of Aarti Pharmalabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, AARTIPHARM stock has moved up by 3.7%
MF Holding Up
Mutual Funds have increased holdings from 2.05% to 2.72% in Mar 2024 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 42.87 Cr → 52.76 Cr (in ₹), with an average increase of 6.6% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 440.78 Cr → 450.08 Cr (in ₹), with an average increase of 2.1% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 8.16% to 8.33% in Mar 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 46.46% of holdings in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 35.46% to 35.23% in Mar 2024 quarter
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (24.21x)
April 23, 2024
Industry (61.41x)
April 23, 2024
Highest (25.98x)
February 7, 2024
Funds | Holdings |
Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth | 0.19% |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 0.69% |
HDFC Multi Cap Fund Direct Growth | 0.15% |
Quant Business Cycle Fund Direct Growth | 1.31% |
Quant Healthcare Fund Direct Growth | 2.64% |
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 46.46% | 0.00 | |
Foreign Institutions | 8.32% | 0.00 | |
Mutual Funds | 2.72% | 0.00 | |
Retail Investors | 35.23% | 0.00 | |
Others | 7.26% | 0.00 |
Technicals of Aarti Pharmalabs Ltd share
News & Events of Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd (AARTIPHARM) share price today is ₹521.6
Aarti Pharmalabs Ltd is listed on NSE
Aarti Pharmalabs Ltd is listed on BSE
PE Ratio of Aarti Pharmalabs Ltd is 24.21
PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share
Today’s traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 2.00L.
Today’s market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹4709.83Cr.
Aarti Pharmalabs Ltd(AARTIPHARM | Price |
---|---|
52 Week High | ₹594.9 |
52 Week Low | ₹321 |
Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹521.6. It is down -12.32% from its 52 Week High price of ₹594.9
Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹521.6. It is up 62.49% from its 52 Week Low price of ₹321
Aarti Pharmalabs Ltd(AARTIPHARM | Returns |
---|---|
1 Day Returns | 1.6% |
1 Month Returns | 16.76% |
3 Month Returns | -3.32% |
1 Year Returns | 46.83% |